Marko Laboratory: Funding

The University of Illinois at Chicago (1996-2006)
The Whitaker Foundation (1997-2001)
The National Science Foundation (1997-present)
   by grants DMR-9734178, DMR-0203963, MCB-0240998, PHY-0445565,
   DMR-0715099, PHY-0852130, MCB-1022117,
   DMR-0520513 (NU-MRSEC), DMR-1121262 (NU-MRSEC) and DMR-1206868
The Petroleum Research Foundation of the American Chemical Society (1998-2001)
The Research Corporation (1999-2002)
The Johnson & Johnson Corporation (1999-2003)
The National Institutes of Health (2004-2006, 2009-present)
   by subcontract to New York University under grant R21-GM-71019,
   by grants U54-CA143869 (NU-PS-OC) and U54-CA193419 (CR-PS-OC),
   by subcontract to the University of Pittsburgh under grant R01-AI059114,
   by grant U54-HD076188 (NU Center for Reproductive Health After Disease),
   by grant R01-GM105847,
   by subcontract to the University of Massachusetts under grants U54-DK107980 and UM1-HG011536 (Center for 3D Structure and Physics of the Genome, 4DN Consortium),
   and by subcontract to the University of Illinois under grant R01-GM135549
Northwestern University (2006-present)
The Chicago Biomedical Consortium, funded by the Searle Funds at the Chicago Community Trust (2006-2008, 2013-2015)

   by 2006 and 2013 Catalyst awards
The Robert H. Lurie Comprehensive Cancer Center (2010-present)
via NIH support grant P30 CA060553